Development of novel tracers for sentinel node identification in cervical cancer.

Keisuke Kodama, Chuya Tateishi, Tsuyoshi Oda, Lin Cui, Kazutaka Kuramoto, Hideaki Yahata, Kaoru Okugawa, Shoji Maenohara, Hiroshi Yagi, Masafumi Yasunaga, Ichiro Onoyama, Kazuo Asanoma, Takeshi Mori, Yoshiki Katayama, Kiyoko Kato
Author Information
  1. Keisuke Kodama: Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. ORCID
  2. Chuya Tateishi: Department of Chemistry and Biochemistry, Graduate School of Systems Life Sciences, Graduate School of Engineering, Kyushu University, Fukuoka, Japan.
  3. Tsuyoshi Oda: Department of Chemistry and Biochemistry, Graduate School of Systems Life Sciences, Graduate School of Engineering, Kyushu University, Fukuoka, Japan.
  4. Lin Cui: Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  5. Kazutaka Kuramoto: Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  6. Hideaki Yahata: Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  7. Kaoru Okugawa: Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  8. Shoji Maenohara: Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  9. Hiroshi Yagi: Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  10. Masafumi Yasunaga: Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  11. Ichiro Onoyama: Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  12. Kazuo Asanoma: Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  13. Takeshi Mori: Department of Chemistry and Biochemistry, Graduate School of Systems Life Sciences, Graduate School of Engineering, Kyushu University, Fukuoka, Japan.
  14. Yoshiki Katayama: Department of Chemistry and Biochemistry, Graduate School of Systems Life Sciences, Graduate School of Engineering, Kyushu University, Fukuoka, Japan.
  15. Kiyoko Kato: Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Abstract

Indocyanine green (ICG) with near-infrared (NIR) fluorescence imaging is used for lymphatic mapping. However, binding of ICG to blood proteins like serum albumin can shorten its retention time in sentinel lymph nodes (SLNs). Here, we investigated the efficacy and safety of a new fluorescence tracer comprising phytate and liposome (LP)-encapsulated ICG. Coadministration of phytate with LP containing phosphatidic acid promotes chelation mediated by Ca in bodily fluids to enhance SLN retention. Uniformly sized LPs (100 nm) encapsulating ICG under conditions that minimized fluorescence self-quenching during storage were produced. We analyzed the behavior of the new tracer (ICG-phytate-LP) and control tracers (ICG and ICG-LP) in the lymphatic flow of mice in terms of lymph node retention time. We also tested lymphatic flow and safety in pigs that have a more human-like lymphatic system. LPs encapsulating stabilized ICG were successfully prepared. Mixing LP with phytate in the presence of Ca increased both the particle size and negative surface charge. In mice, ICG-phytate-LP had the best lymph node retention, with a fluorescence intensity ratio that increased over 6 h and then decreased slowly over the next 24 h. In pigs, administration of ICG and ICG-phytate-LP resulted in no death or weight loss. There were no obvious differences between blood test results for the ICG and ICG-phytate-LP groups, and the overall safety was good. ICG-phytate-LP may be a useful new tracer for gynecological cancers that require time for lymph node identification due to a retroperitoneal approach.

Keywords

References

  1. Otolaryngol Head Neck Surg. 2014 Aug;151(2):279-85 [PMID: 24732687]
  2. Pharmaceutics. 2021 Sep 14;13(9): [PMID: 34575540]
  3. Int J Clin Oncol. 2021 May;26(5):971-979 [PMID: 33768450]
  4. Medicine (Baltimore). 2021 Aug 27;100(34):e27035 [PMID: 34449483]
  5. Cancer Res Treat. 2018 Jul;50(3):964-974 [PMID: 29081219]
  6. Chin Clin Oncol. 2021 Apr;10(2):18 [PMID: 33951917]
  7. Mol Imaging. 2005 Jul-Sep;4(3):172-81 [PMID: 16194449]
  8. Mol Ther. 2021 Jan 6;29(1):225-235 [PMID: 32966771]
  9. J Chromatogr B Biomed Sci Appl. 1999 Jun 11;729(1-2):55-64 [PMID: 10410927]
  10. Cancer Sci. 2023 Nov;114(11):4216-4224 [PMID: 37648257]
  11. Crit Rev Oncol Hematol. 2021 Feb;158:103149 [PMID: 33450679]
  12. J Obstet Gynaecol Res. 2021 Jun;47(6):2175-2184 [PMID: 33765693]
  13. Front Oncol. 2022 Jan 27;12:817510 [PMID: 35155254]
  14. Biochemistry. 2014 Mar 4;53(8):1275-83 [PMID: 24512123]
  15. Gynecol Oncol. 2022 Apr;165(1):149-154 [PMID: 35151491]
  16. J Nucl Med. 1981 Feb;22(2):157-60 [PMID: 7470231]
  17. J Drug Target. 2018 Jun - Jul;26(5-6):494-504 [PMID: 29388438]
  18. Gynecol Oncol. 2021 May;161(2):436-441 [PMID: 33551201]
  19. Gynecol Oncol. 1989 Dec;35(3):314-20 [PMID: 2599466]
  20. Fertil Steril. 2021 Jul;116(1):269-271 [PMID: 33840452]
  21. Curr Opin Biotechnol. 2007 Feb;18(1):17-25 [PMID: 17234399]
  22. Int J Gynecol Cancer. 2020 May;30(5):602-606 [PMID: 32156715]
  23. Cancer Res. 2010 Sep 15;70(18):7053-62 [PMID: 20823159]
  24. Cancer Med. 2021 Apr;10(8):2590-2600 [PMID: 33314779]
  25. Int J Clin Oncol. 2010 Feb;15(1):52-8 [PMID: 20087618]
  26. Head Neck Oncol. 2010 Oct 30;2:31 [PMID: 21034503]
  27. Laryngoscope. 2022 Nov;132(11):2164-2168 [PMID: 35199860]
  28. J Clin Oncol. 2005 Oct 20;23(30):7703-20 [PMID: 16157938]
  29. Oncol Lett. 2021 Feb;21(2):114 [PMID: 33376546]
  30. Arch Surg. 1992 Apr;127(4):392-9 [PMID: 1558490]
  31. Minerva Urol Nefrol. 2018 Aug;70(4):361-369 [PMID: 29241310]
  32. J Cancer Res Clin Oncol. 2021 Mar;147(3):649-659 [PMID: 33000339]
  33. Gynecol Oncol. 2010 Apr;117(1):53-8 [PMID: 20061005]
  34. ACS Appl Mater Interfaces. 2017 Feb 22;9(7):5683-5691 [PMID: 28152314]
  35. Int J Clin Oncol. 2018 Dec;23(6):1167-1172 [PMID: 30094694]
  36. Microvasc Res. 1998 Mar;55(2):146-52 [PMID: 9521889]

Grants

  1. FAKF401232/Grant-in-Aid for Scientific Research, Kyushu University School of Medicine Obstetrics and Gynecology Research Fund
  2. JP19K09804/Japan Society for the Promotion of Science

MeSH Term

Female
Mice
Humans
Swine
Animals
Sentinel Lymph Node
Sentinel Lymph Node Biopsy
Uterine Cervical Neoplasms
Phytic Acid
Lipopolysaccharides
Lymph Nodes
Indocyanine Green

Chemicals

Phytic Acid
Lipopolysaccharides
Indocyanine Green

Word Cloud

Created with Highcharts 10.0.0ICGlymphICG-phytate-LPnodefluorescencelymphaticretentiontracerphytatetimesentinelsafetynewLPgreenbloodliposomeCaLPsencapsulatingtracersflowmicepigsincreasedidentificationIndocyaninenear-infraredNIRimagingusedmappingHoweverbindingproteinslikeserumalbumincanshortennodesSLNsinvestigatedefficacycomprising-encapsulatedCoadministrationcontainingphosphatidicacidpromoteschelationmediatedbodilyfluidsenhanceSLNUniformlysized100 nmconditionsminimizedself-quenchingstorageproducedanalyzedbehaviorcontrolICG-LPtermsalsotestedhuman-likesystemstabilizedsuccessfullypreparedMixingpresenceparticlesizenegativesurfacechargebestintensityratio6 hdecreasedslowlynext24 hadministrationresulteddeathweightlossobviousdifferencestestresultsgroupsoverallgoodmayusefulgynecologicalcancersrequiredueretroperitonealapproachDevelopmentnovelcervicalcancerindocyanine

Similar Articles

Cited By